McKesson Can't Ditch Generic Drug Price-Fixing Fraud Suit
McKesson Corp. must face securities fraud claims over its alleged participation in an industry-wide generic drug price-fixing scheme, a California federal court ruled Wednesday, denying the drug wholesaler's bid to escape...To view the full article, register now.
Already a subscriber? Click here to view full article